SNGX Insider Trading - Soligenix, Inc.

已發行股份	10,306,079 shares
內部人士股份	5,126,831 shares
內部持股	49.75 %
所有內部人士	32

內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果，該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例，以及內部人士擁有的總股份的指標。該分數的範圍從0到100，數值越高表示相對於同行業而言具有更高程度的內部人士持股水平，50為平均值。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義，公司高管是公司內部人士，但與其他內部人士（10%的股東和董事會成員）不同，公司高管每天在公司工作，而且他們使用自己的資金進行交易。（10%的股東和董事會成員通常是基金經理，管理著其他人的資金。）因此，公司高管進行的內幕交易更為重要性，應該被適當地重視和關注。

如同「內部人士情緒分數」，「高管情緒分數」也是一個複雜的多因素量化模型的計算結果，該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率：每日

查閱「內部人士首選」，該清單呈現被內部人士購入最多的公司。

查閲高排名股票

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說，一般認為內部人士的買入是一個積極的指標，因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少（甚至有內部人士賣出）的公司。

內部人士買入淨數（排名）

0 ( )

9080 out of 10916

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示（範圍從0到100%）。

內部人士買入佔流通股比例（排名）

0.000% ( )

8984 out of 10752

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數，除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Soligenix, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單，從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外，我們還提供了最新披露的持股信息。此外，我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊，請查看YouTube網絡研討會。

See our leaderboard of most profitable insider traders.

內部人士	持股數量	分拆調整
Robert N Brey	10,000
Keith L Brownlie Director - [D]	50,000	3,659
Marco Maria Brughera Director - [D]	2,750	177
Cyrille F Buhrman Director - [D]	4,900,020	4,900,020
Paolo Cavazza -	293,510	18,936
Enrico Cavazza -	293,510	18,936
Francesca Cavazza -	293,510	18,936
Preta Martina Cavazza -	293,510	18,936
Silvia Cavazza -	293,510	18,936
Cote Timothy R. Director - [D]	50,634	3,165

內部人士	持股數量	分拆調整
Oreola Donini	70,000
Corp Plc Elan 10% Owner - [10%]	162,600	162,600
Elan International Services Ltd 10% Owner - [10%]	162,600	162,600
Elan Pharmaceutical Investments Ii Ltd 10% Owner - [10%]	1,468,900	1,468,900
Elan Pharmaceutical Investments Ltd 10% Owner - [10%]	162,600	162,600
SPA Essetifin -	293,510	18,936
Guarino Jonathan L. Senior Vice President and CFO - [O]	11,000	710
Kevin Horgan	85,000
Corp Intrexon 10% Owner - [10%]	85,397	5,509
Randal J Kirk 10% Owner - [10%]	85,397	5,509
Karen R Krumeich SVP and CFO - [O]	26,000	1,902

內部人士	持股數量	分拆調整
Anthony Gregg Lapointe Director - [D]	73,781	5,399
Leadiant Biosciences, Inc. 10% Owner - [10%]	293,510	18,936
Parks Diane L. Director - [D]	14,940	964
Pearson Mark E. Director, 10% Owner - [D] [10%]	78,338	5,054
Rubin Robert J. Director - [D]	4,385	283
Christopher J Schaber CHAIRMAN, CEO AND PRESIDENT, Director - [D] [O]	15,511	15,511
Sigma Tau International Sa 10% Owner - [10%]	2,711,393	3,967,889
Sigma-Tau America S.A. 10% Owner - [10%]	2,711,393	3,967,889
Richard Straube SENIOR VICE PRESIDENT AND CMO - [O]	8,000	516
Joseph Michael Warusz VP of Finance/Acting CFO - [O]	12,955	948
Jerome B Zeldis Director - [D]	22,917	1,479

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分，我們分析了在 SNGX / Soligenix, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格	最高淨利 ($)	最高回報率（%）
2025-10-02	SCHABER CHRISTOPHER J	15,132	1.3217	15,132	1.3217	20,000	6	1.8100	7,390	36.95
2022-05-18	Straube Richard	8,000	0.5000	516	7.7500	4,000
2022-05-18	SCHABER CHRISTOPHER J	20,000	0.4433	1,290	6.8712	8,866
2021-12-17	SCHABER CHRISTOPHER J	7,000	0.7399	452	11.4684	5,179
2021-12-15	Guarino Jonathan L.	1,000	0.7000	65	10.8500	700
2021-12-14	Guarino Jonathan L.	10,000	0.7119	645	11.0344	7,119
2021-12-14	SCHABER CHRISTOPHER J	10,000	0.7269	645	11.2670	7,269
2021-05-14	ZELDIS JEROME B	3,000	0.8880	194	13.7640	2,664
2019-11-19	ZELDIS JEROME B	2,000	0.9250	129	14.3375	1,850

經調整價格已按拆股調整。經調整股數已按拆股調整。

追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分，我們分析了在 SNGX / Soligenix, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	內部人士	報告股數	報告價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
2021-05-14	ZELDIS JEROME B	3,000	0.9002	194	13.9531	2,701	17	1.02	-2,503	-92.71
2017-11-29	Essetifin SPA	16,416	2.1200	1,059	32.8600	34,802
2017-11-29	Essetifin SPA	5,954	2.1200	384	32.8600	12,622
2017-11-29	Essetifin SPA	271,140	2.1200	17,493	32.8600	574,817
2017-05-08	KIRK RANDAL J	1,881	2.5400	121	39.3700	4,778
2017-05-08	KIRK RANDAL J	9,695	2.5400	625	39.3700	24,625
2017-05-05	KIRK RANDAL J	13,893	2.7000	896	41.8500	37,511
2017-05-05	KIRK RANDAL J	71,607	2.7000	4,620	41.8500	193,339
2017-05-04	KIRK RANDAL J	2,278	2.9700	147	46.0350	6,766

經調整價格已按拆股調整。經調整股數已按拆股調整。

交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易，將在標記為 10b-5 的欄位中顯示 X。

呈報日期	交易日期	表格	內部人士	證券代碼	證券種類	代碼	直接	行使價格	單位價格	股數變化	價值變化 (1K)	剩餘期權	剩餘股份
2025-10-03	2025-10-02	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		1.3217	15,132	20		15,511
2023-05-05		3	Cote Timothy R. Silk Road Therapeutics, Inc.	SNGX	Common Stock		I						25,317
2022-05-18	2022-05-18	4	Straube Richard	SNGX	COMMON STOCK	P - Purchase	D		0.5000	8,000	4		8,000
2022-05-18	2022-05-18	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		0.4433	20,000	9		90,095
2022-01-21	2022-01-21	4	Guarino Jonathan L.	SNGX	Option (Right to Buy)	A - Award	D	0.78		50,000		50,000
2022-01-21	2022-01-21	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	0.69		47,315		47,315
2022-01-04	2022-01-03	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	0.69		60,000		60,000
2021-12-20	2021-12-17	4	SCHABER CHRISTOPHER J	SNGX	COMMON STOCK	P - Purchase	D		0.7399	7,000	5		70,095
2021-12-15	2021-12-15	4	Guarino Jonathan L.	SNGX	COMMON STOCK	P - Purchase	D		0.7000	1,000	1		11,000
2021-12-15	2021-12-14	4	Guarino Jonathan L.	SNGX	COMMON STOCK	P - Purchase	D		0.7119	10,000	7		10,000
2021-12-14	2021-12-14	4	SCHABER CHRISTOPHER J	SNGX	COMMON STOCK	P - Purchase	D		0.7269	10,000	7		63,095
2021-12-10	2021-12-09	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	0.78		60,000		60,000
2021-12-10	2021-12-09	4	Guarino Jonathan L.	SNGX	Stock Option (Right to Buy)	A - Award	D	0.78		50,000		50,000
2021-12-10	2021-12-09	4	Donini Oreola	SNGX	Option (Right to Buy)	A - Award	D	0.78		70,000		70,000
2021-12-10	2021-12-09	4	Straube Richard	SNGX	Option (Right to Buy)	A - Award	D	0.78		40,000		40,000
2021-09-24	2021-09-23	4	Parks Diane L.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.03		29,126		29,126
2021-09-24	2021-09-23	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	1.03		29,126		29,126
2021-09-24	2021-09-23	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	1.03		29,126		29,126
2021-09-24	2021-09-23	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.03		29,126		29,126
2021-05-18	2021-05-14	4	ZELDIS JEROME B	SNGX	Common Stock	S - Sale	D		0.9002	-3,000	-3		22,917
2021-05-18	2021-05-14	4	ZELDIS JEROME B	SNGX	Common Stock	P - Purchase	D		0.8880	3,000	3		25,917
2021-01-04	2021-01-04	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	1.28		60,000		60,000
2020-12-11	2020-12-10	4	Donini Oreola	SNGX	Option (Right to Buy)	A - Award	D	2.34		70,000		70,000
2020-12-11	2020-12-10	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	2.34		60,000		60,000
2020-12-11	2020-12-10	4	Straube Richard	SNGX	Option (Right to Buy)	A - Award	D	2.34		40,000		40,000
2020-12-11	2020-12-10	4	Guarino Jonathan L.	SNGX	Stock Option (Right to Buy)	A - Award	D	2.34		40,000		40,000
2020-09-18	2020-09-16	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	1.97		15,228		15,228
2020-09-18	2020-09-16	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	1.97		15,228		15,228
2020-09-18	2020-09-16	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.97		15,228		15,228
2020-09-18	2020-09-16	4	Parks Diane L.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.97		15,228		15,228
2020-06-19	2020-06-18	4	Parks Diane L.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.76		13,500		13,500
2020-01-02	2020-01-02	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	1.45		60,000		60,000
2019-12-13	2019-12-12	4	Donini Oreola	SNGX	Option (Right to Buy)	A - Award	D	1.24		60,000		60,000
2019-12-13	2019-12-12	4	Guarino Jonathan L.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.24		10,000		10,000
2019-12-13	2019-12-12	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	1.24		60,000		60,000
2019-12-13	2019-12-12	4	Straube Richard	SNGX	Option (Right to Buy)	A - Award	D	1.24		30,000		30,000
2019-11-19	2019-11-19	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		0.9300	10,770	10		53,095
2019-11-19	2019-11-19	4	ZELDIS JEROME B	SNGX	Common Stock	P - Purchase	D		0.9250	2,000	2		22,917
2019-09-23	2019-09-23	4	Parks Diane L.	SNGX	Common Stock	P - Purchase	D		0.9284	14,940	14		14,940
2019-09-23	2019-09-19	4	ZELDIS JEROME B	SNGX	Common Stock	P - Purchase	D		0.9350	4,000	4		20,917
2019-09-11	2019-09-09	4	Guarino Jonathan L.	SNGX	Stock Option (Right to Buy)	A - Award	D	0.97		40,000		40,000
2019-09-10	2019-09-06	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	0.97		30,928		30,928
2019-09-10	2019-09-06	4	Parks Diane L.	SNGX	Stock Option (Right to Buy)	A - Award	D	0.97		30,928		30,928
2019-09-10	2019-09-06	4	Pearson Mark E.	SNGX	Stock Option (Right to Buy)	A - Award	D	0.97		30,928		30,928
2019-09-10	2019-09-06	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	0.97		30,928		30,928
2019-09-10	2019-09-06	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	0.97		30,928		30,928
2019-07-10	2019-06-28	4	Pearson Mark E.	SNGX	Common Stock	A - Award	I		0.7100	78,338	56		78,338
2019-07-08	2019-07-08	4	Parks Diane L.	SNGX	Stock Option (Right to Buy)	A - Award	D	0.86		1,500		1,500
2019-04-22	2019-04-22	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		0.7154	5,000	4		42,325
2019-04-22	2019-04-22	4	ZELDIS JEROME B	SNGX	Common Stock	P - Purchase	D		0.7274	10,000	7		16,917
2019-01-04	2019-01-02	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	0.96		60,000		60,000
2018-12-14	2018-12-13	4	Donini Oreola	SNGX	Option (Right to Buy)	A - Award	D	0.97		40,000		40,000
2018-12-14	2018-12-13	4	Krumeich Karen R	SNGX	Option (Right to Buy)	A - Award	D	0.97		40,000		40,000
2018-12-14	2018-12-13	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	0.97		60,000		60,000
2018-12-14	2018-12-13	4	Straube Richard	SNGX	Option (Right to Buy)	A - Award	D	0.97		40,000		40,000
2018-10-18	2018-10-18	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		1.1698	8,700	10		37,325
2018-10-17	2018-10-17	4	Pearson Mark E.	SNGX	Common Stock	P - Purchase	D		1.1600	170,000	197		2,500,000
2018-09-28	2018-09-27	4	Brownlie Keith L	SNGX	Stock Option (Right to Buy)	A - Award	D	1.67		17,964		17,964
2018-09-28	2018-09-27	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	1.67		17,964		17,964
2018-09-28	2018-09-27	4	Pearson Mark E.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.67		17,964		17,964
2018-09-28	2018-09-27	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.67		17,964		17,964
2018-09-28	2018-09-27	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	1.67		17,964		17,964
2018-08-22	2018-08-22	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		1.4198	3,530	5		28,625
2018-07-25		3	Pearson Mark E.	SNGX	COMMON STOCK		D						4,660,000
2018-07-25		3	Pearson Mark E.	SNGX	COMMON STOCK		D						4,660,000
2018-07-25		3	Pearson Mark E.	SNGX	COMMON STOCK		D						4,660,000
2018-07-25	2018-07-20	4	Pearson Mark E.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.22		1,500		1,500
2017-12-11	2017-12-07	4	Donini Oreola	SNGX	Option (Right to Buy)	A - Award	D	2.01		35,000		35,000
2017-12-11	2017-12-07	4	Krumeich Karen R	SNGX	Option (Right to Buy)	A - Award	D	2.01		35,000		35,000
2017-12-11	2017-12-07	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	2.01		80,000		80,000
2017-12-11	2017-12-07	4	Straube Richard	SNGX	Option (Right to Buy)	A - Award	D	2.01		35,000		35,000
2017-12-01	2017-11-29	4	Essetifin SPA	SNGX	Common Stock	P - Purchase	D		2.1200	16,416	35		293,510
2017-12-01	2017-11-29	4	Essetifin SPA Indirect	SNGX	Common Stock	S - Sale	I		2.1200	-16,416	-35		0
2017-12-01	2017-11-29	4	Essetifin SPA	SNGX	Common Stock	P - Purchase	D		2.1200	5,954	13		277,094
2017-12-01	2017-11-29	4	Essetifin SPA Indirect	SNGX	Common Stock	S - Sale	I		2.1200	-5,954	-13		0
2017-12-01	2017-11-29	4	Essetifin SPA	SNGX	Common Stock	P - Purchase	D		2.1200	271,140	575		271,140
2017-12-01	2017-11-29	4	Essetifin SPA Indirect	SNGX	Common Stock	S - Sale	I		2.1200	-271,140	-575		0
2017-06-12	2017-06-08	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	2.29		13,100		13,100
2017-06-12	2017-06-08	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	2.29		13,100		13,100
2017-06-12	2017-06-08	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	2.29		13,100		13,100
2017-06-12	2017-06-08	4	Brughera Marco Maria	SNGX	Stock Option (Right to Buy)	A - Award	D	2.29		13,100		13,100
2017-06-12	2017-06-08	4	Brownlie Keith L	SNGX	Stock Option (Right to Buy)	A - Award	D	2.29		13,100		13,100
2017-05-08	2017-05-08	4	KIRK RANDAL J by Intrexon	SNGX	Common Stock	S - Sale	I		2.5400	-1,881	-5		85,397
2017-05-08	2017-05-08	4	KIRK RANDAL J by NRM VII Holdings	SNGX	Common Stock	S - Sale	I		2.5400	-9,695	-25		440,418
2017-05-08	2017-05-05	4	KIRK RANDAL J by Intrexon	SNGX	Common Stock	S - Sale	I		2.7000	-13,893	-38		87,278
2017-05-08	2017-05-05	4	KIRK RANDAL J by NRM VII Holdings	SNGX	Common Stock	S - Sale	I		2.7000	-71,607	-193		450,113
2017-05-08	2017-05-04	4	KIRK RANDAL J by NRM VII Holdings	SNGX	Warrant to Purchase Common Stock	X - Other	I	0.80		-250,000		0
2017-05-08	2017-05-04	4	KIRK RANDAL J by Intrexon	SNGX	Common Stock	S - Sale	I		2.9700	-2,278	-7		101,171
2017-05-08	2017-05-04	4	KIRK RANDAL J by NRM VII Holdings	SNGX	Common Stock	S - Sale	I		2.9700	-11,739	-35		521,720
2017-05-08	2017-05-04	4	KIRK RANDAL J by NRM VII Holdings	SNGX	Common Stock	S - Sale	I		4.0100	-49,875	-200		533,459
2017-05-08	2017-05-04	4	KIRK RANDAL J by NRM VII Holdings	SNGX	Common Stock	X - Other	I		0.8000	250,000	200		583,334
2017-04-04	2017-03-31	4	Donini Oreola	SNGX	Option (Right to Buy)	A - Award	D	2.67		20,000		20,000
2017-04-04	2017-03-31	4	Krumeich Karen R	SNGX	Option (Right to Buy)	A - Award	D	2.67		20,000		20,000
2017-04-04	2017-03-31	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	2.67		50,000		50,000
2017-04-04	2017-03-31	4	Straube Richard	SNGX	Option (Right to Buy)	A - Award	D	2.67		20,000		20,000
2016-12-20	2016-12-16	4	Brughera Marco Maria	SNGX	Common Stock Warrant	P - Purchase	D	3.95	0.0001	2,500	0	2,500
2016-12-20	2016-12-16	4	Brughera Marco Maria	SNGX	Common Stock	P - Purchase	D		3.1599	2,000	6		2,750
2016-12-20	2016-12-16	4	RUBIN ROBERT J.	SNGX	Common Stock Warrant	P - Purchase	D	3.95	0.0001	3,956	0	3,956
2016-12-20	2016-12-16	4	RUBIN ROBERT J.	SNGX	Common Stock	P - Purchase	D		3.1599	3,165	10		4,385
2016-12-20	2016-12-16	4	SCHABER CHRISTOPHER J	SNGX	Common Stock Warrant	P - Purchase	D	3.95	0.0001	19,755	0	19,755
2016-12-20	2016-12-16	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		3.1599	15,804	50		25,095
2016-06-22		3	Krumeich Karen R	SNGX	Common Stock		D						26,000
2016-06-22		3	Krumeich Karen R	SNGX	Common Stock		D						26,000
2016-06-22	2016-06-16	4	Krumeich Karen R	SNGX	Option (Right to Buy)	A - Award	D	0.74		100,000		100,000
2016-06-20	2016-06-16	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	0.74		40,541		40,541
2016-06-20	2016-06-16	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	0.74		40,541		40,541
2016-06-20	2016-06-16	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	0.74		40,541		40,541
2016-06-20	2016-06-16	4	Brughera Marco Maria	SNGX	Stock Option (Right to Buy)	A - Award	D	0.74		40,541		40,541
2016-06-20	2016-06-16	4	Brownlie Keith L	SNGX	Stock Option (Right to Buy)	A - Award	D	0.74		40,541		40,541
2016-01-04	2015-12-31	4	Donini Oreola	SNGX	Stock Option (Right to Buy)	A - Award	D	1.13		70,000		70,000
2016-01-04	2015-12-31	4	Straube Richard	SNGX	Stock Option (Right to Buy)	A - Award	D	1.13		70,000		70,000
2016-01-04	2015-12-31	4	Warusz Joseph Michael	SNGX	Option (Right to Buy)	A - Award	D	1.13		55,000		55,000
2016-01-04	2015-12-31	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	1.13		140,000		140,000
2015-12-23	2015-12-23	4	ZELDIS JEROME B	SNGX	Common Stock	P - Purchase	D		1.2700	2,500	3		69,166
2015-12-23	2015-12-22	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		1.2878	10,000	13		85,761
2015-08-31	2015-08-31	4	LAPOINTE ANTHONY GREGG	SNGX	Common Stock Warrant	M - Exercise	D	0.30		-25,000		0
2015-08-31	2015-08-31	4	LAPOINTE ANTHONY GREGG	SNGX	Common Stock	M - Exercise	D		0.3000	25,000	8		73,781
2015-07-01	2015-07-01	4	SCHABER CHRISTOPHER J	SNGX	Common Stock Warrant	M - Exercise	D	0.61		-7,143		0
2015-07-01	2015-07-01	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	M - Exercise	D		0.6100	7,143	4		82,904
2015-06-19	2015-06-18	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	1.51		19,868		19,868
2015-06-19	2015-06-18	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	1.51		19,868		19,868
2015-06-19	2015-06-18	4	Brughera Marco Maria	SNGX	Stock Option (Right to Buy)	A - Award	D	1.51		19,868		19,868
2015-06-19	2015-06-18	4	Brownlie Keith L	SNGX	Stock Option (Right to Buy)	A - Award	D	1.51		19,868		19,868
2015-06-19	2015-06-18	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	1.51		19,868		19,868
2015-04-09	2015-04-09	4	Brownlie Keith L	SNGX	Common Stock Warrant	M - Exercise	D	0.61		-14,286		0
2015-04-09	2015-04-09	4	Brownlie Keith L	SNGX	Common Stock	M - Exercise	D		0.6100	14,286	9		50,000
2015-04-09	2015-04-09	4	ZELDIS JEROME B	SNGX	Common Stock Warrant	M - Exercise	D	0.61		-17,857		0
2015-04-09	2015-04-09	4	ZELDIS JEROME B	SNGX	Common Stock	M - Exercise	D		0.6100	17,857	11		66,666
2014-12-24	2014-12-24	4	Warusz Joseph Michael	SNGX	Common Stock Warrant	P - Purchase	D	1.48		4,959		4,959
2014-12-24	2014-12-22	4	Warusz Joseph Michael	SNGX	Common Stock	P - Purchase	D		1.2100	8,265	10		12,955
2014-12-24	2014-12-24	4	SCHABER CHRISTOPHER J	SNGX	Common Stock Warrant	P - Purchase	D	1.48		4,959		4,959
2014-12-24	2014-12-22	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		1.2100	8,265	10		75,761
2014-12-08	2014-12-04	4	Warusz Joseph Michael	SNGX	Option (Right to Buy)	A - Award	D	1.50		45,000		45,000
2014-12-08	2014-12-04	4	Straube Richard	SNGX	Stock Option (Right to Buy)	A - Award	D	1.50		50,000		50,000
2014-12-08	2014-12-04	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	A - Award	D	1.50		100,000		100,000
2014-08-05	2014-08-05	4	Brughera Marco Maria	SNGX	Stock Option (Right to Buy)	M - Exercise	D	2.01		-7,500		7,500
2014-08-05	2014-08-05	4	Brughera Marco Maria	SNGX	Common Stock	M - Exercise	D		2.0100	7,500	15		7,500
2014-06-20	2014-06-19	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	2.19		13,669		13,669
2014-06-20	2014-06-19	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	2.19		13,669		13,669
2014-06-20	2014-06-19	4	Brownlie Keith L	SNGX	Stock Option (Right to Buy)	A - Award	D	2.19		13,669		13,669
2014-06-20	2014-06-19	4	Brughera Marco Maria	SNGX	Stock Option (Right to Buy)	A - Award	D	2.19		13,669		13,669
2014-06-20	2014-06-19	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	2.19		13,669		13,669
2014-05-19	2014-05-19	4	Warusz Joseph Michael	SNGX	Option (Right to Buy)	M - Exercise	D	0.64		-4,690		25,310
2014-05-19	2014-05-19	4	Warusz Joseph Michael	SNGX	Common Stock	M - Exercise	D		0.6400	4,690	3		4,690
2014-05-16	2014-05-14	4	Brownlie Keith L	SNGX	Option (Right to Buy)	M - Exercise	D	0.30		-16,667		8,333
2014-05-16	2014-05-14	4	Brownlie Keith L	SNGX	Common Stock	M - Exercise	D		0.3000	16,667	5		35,714
2014-05-14	2014-05-13	4	SCHABER CHRISTOPHER J	SNGX	Option (Right to Buy)	M - Exercise	D	0.64		-7,815		112,185
2014-05-14	2014-05-13	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	M - Exercise	D		0.6400	7,815	5		67,496
2014-01-08	2014-01-06	4	Straube Richard	SNGX	Stock Option (Right to Buy)	A - Award	D	2.01		100,000		100,000
2013-12-09	2013-12-05	4	BREY ROBERT N	SNGX	Stock Option (Right to Buy)	A - Award	D	2.01		10,000		10,000
2013-12-09	2013-12-05	4	Brughera Marco Maria	SNGX	Stock Option (Right to Buy)	A - Award	D	2.01		15,000		15,000
2013-12-09	2013-12-05	4	SCHABER CHRISTOPHER J	SNGX	Stock Option (Right to Buy)	A - Award	D	2.01		100,000		100,000
2013-12-09	2013-12-05	4	Warusz Joseph Michael	SNGX	Stock Option (Right to Buy)	A - Award	D	2.01		45,000		45,000
2013-10-01	2013-09-27	4	Brownlie Keith L	SNGX	Stock Option (Right to Buy)	A - Award	D	2.26		13,275		13,275
2013-10-01	2013-09-27	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	2.26		13,275		13,275
2013-10-01	2013-09-27	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	2.26		13,275		13,275
2013-10-01	2013-09-27	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	2.26		13,275		13,275
2013-09-27	2013-09-25	4	BREY ROBERT N	SNGX	Stock Option (Right to Buy)	A - Award	D	0.68		35,000		35,000
2013-09-27	2013-09-25	4	HORGAN KEVIN	SNGX	Stock Option (Right to Buy)	A - Award	D	0.68		85,000		85,000
2013-09-27	2013-09-25	4	SCHABER CHRISTOPHER J	SNGX	Stock Option (Right to Buy)	A - Award	D	0.68		130,000		130,000
2013-09-27	2013-09-25	4	Warusz Joseph Michael	SNGX	Stock Option (Right to Buy)	A - Award	D	0.68		55,000		55,000
2013-06-26		3	INTREXON CORP by Intrexon Corporation	SNGX	Common Stock		I						1,034,483
2013-06-26		3	INTREXON CORP by NRM VII Holdings	SNGX	Common Stock		I						3,333,333
2013-06-26	2013-06-25	4	Brownlie Keith L	SNGX	Common Stock Warrants	P - Purchase	D	1.65		14,286		14,285
2013-06-26	2013-06-25	4	Brownlie Keith L	SNGX	Common Stock	P - Purchase	D		1.0500	19,047	20		19,047
2013-06-26	2013-06-25	4	SCHABER CHRISTOPHER J	SNGX	Common Stock Warrants	P - Purchase	D	1.65		7,143		7,142
2013-06-26	2013-06-25	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		1.0500	9,523	10		59,681
2013-06-26	2013-06-25	4	ZELDIS JEROME B	SNGX	Common Stock Warrants	P - Purchase	D	1.65		17,857		17,857
2013-06-26	2013-06-25	4	ZELDIS JEROME B	SNGX	Common Stock	P - Purchase	D		1.0500	23,809	25		48,809
2013-06-24	2013-06-20	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	M - Exercise	D	0.30		-25,000		0
2013-06-24	2013-06-20	4	ZELDIS JEROME B	SNGX	Common Stock	M - Exercise	D		0.3000	25,000	8		25,000
2012-12-21	2012-12-20	4	CAVAZZA PAOLO Indirect	SNGX	Common Stock Warrant (warrant to buy)	J - Other	I	0.53		1		1
2012-12-21	2012-12-20	4	CAVAZZA PAOLO Indirect	SNGX	Common Stock Warrant (warrant to buy)	J - Other	I	0.53		1		1
2012-12-21	2012-12-20	4	CAVAZZA PAOLO Indirect	SNGX	Common Stock Warrant (warrant to buy)	J - Other	I	5.60		-1		0
2012-12-21	2012-12-20	4	CAVAZZA PAOLO Indirect	SNGX	Common Stock Warrant (warrant to buy)	J - Other	I	5.60		-1		0
2012-12-21	2012-12-20	4	CAVAZZA PAOLO Indirect	SNGX	Common Stock Warrant (warrant to buy)	J - Other	I	5.60		-1		0
2012-12-21	2012-12-20	4	Essetifin SPA Indirect	SNGX	Common Stock Warrant (right to buy)	J - Other	I	0.53		1		1
2012-12-21	2012-12-20	4	Essetifin SPA Indirect	SNGX	Common Stock Warrant (right to buy)	J - Other	I	5.60		-1		0
2012-12-21	2012-12-20	4	Essetifin SPA Indirect	SNGX	Common Stock Warrant (right to buy)	J - Other	I	5.60		-1		0
2012-07-25	2012-06-21	4	Brownlie Keith L	SNGX	Stock Option (Right to Buy)	A - Award	D	0.30		25,000		25,000
2012-07-25	2012-06-21	4	LAPOINTE ANTHONY GREGG	SNGX	Stock Option (Right to Buy)	A - Award	D	0.30		25,000		25,000
2012-07-25	2012-06-21	4	RUBIN ROBERT J.	SNGX	Stock Option (Right to Buy)	A - Award	D	0.30		25,000		25,000
2012-07-25	2012-06-21	4	ZELDIS JEROME B	SNGX	Stock Option (Right to Buy)	A - Award	D	0.30		25,000		25,000
2012-04-11	2012-04-10	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	P - Purchase	D		0.5098	9,900	5		50,157
2012-01-18	2012-01-16	4	SCHABER CHRISTOPHER J	SNGX	Common Stock	A - Award	D			333,333			805,150
2010-06-22	2010-06-18	4	RUBIN ROBERT J.	SNGX	Common Stock	P - Purchase	D		0.2050	243,902	50		243,902
2010-06-21	2010-06-18	4	Essetifin SPA Indirect	SNGX	Common Stock Warrant (right to buy)	J - Other	I	0.28		1		1
2010-06-21	2010-06-18	4	Essetifin SPA Indirect	SNGX	Common Stock	P - Purchase	I		0.2050	8,608,580	1,765		54,227,816
2009-09-28	2009-09-24	4	Essetifin SPA Indirect	DORB	Common Stock Warrant (right to buy)	J - Other	I	0.28		1		1
2009-09-28	2009-09-24	4	Essetifin SPA Indirect	DORB	Common Stock	P - Purchase	I		0.2530	3,952,569	1,000		45,619,236
2009-02-13	2009-02-11	4	Essetifin SPA Indirect	DORB	Common Stock	P - Purchase	I		0.1800	25,000,000	4,500		41,666,667
2008-12-03		3	Leadiant Biosciences, Inc. Indirect	DORB	Common Stock		I						16,666,667
2007-07-02		3	Buhrman Cyrille F	DORB	Common Stock		D						4,900,020
2007-07-02	2007-06-28	4	Buhrman Cyrille F	DORB	Stock Options (right to buy)	A - Award	D	0.33		150,000		150,000
2004-02-18	2004-02-13	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0100	-875,300	-884		162,600
2004-02-18	2004-02-13	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0200	-248,700	-254		1,037,900
2004-02-18	2004-02-13	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0300	-68,200	-70		1,286,600
2004-02-18	2004-02-13	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0400	-51,300	-53		1,354,800
2004-02-18	2004-02-13	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0600	-12,600	-13		1,406,100
2004-02-18	2004-02-13	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0700	-33,200	-36		1,418,700
2004-02-18	2004-02-13	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0800	-17,000	-18		1,451,900
2004-02-13	2004-02-12	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0100	-180,700	-183		1,468,900
2004-02-13	2004-02-12	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0200	-5,600	-6		1,649,600
2004-02-13	2004-02-12	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0500	-69,200	-73		1,655,200
2004-02-13	2004-02-12	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0600	-11,000	-12		1,724,400
2004-02-13	2004-02-11	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0500	-106,900	-112		1,735,400
2004-02-13	2004-02-11	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0600	-44,900	-48		1,842,300
2004-02-13	2004-02-11	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0700	-4,800	-5		1,887,200
2004-02-13	2004-02-11	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0800	-16,600	-18		1,892,000
2004-02-13	2004-02-11	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.0900	-10,400	-11		1,908,600
2004-02-13	2004-02-11	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.1000	-81,000	-89		1,919,000
2004-02-13	2004-02-11	4	ELAN CORP PLC I	DOR	Common Stock	S - Sale	I		1.1100	-52,879	-59		2,000,000
2004-02-06	2004-02-04	4	ELAN CORP PLC I	DOR	Series B Convertible Preferred Stock	J - Other	I	5.11		126,567		126,567
2004-02-06	2002-12-12	4	ELAN CORP PLC I	DOR	Common Stock	J - Other	I			500,000			2,052,879
2004-02-06	2002-10-21	4	ELAN CORP PLC I	DOR	Series C Convertible Preferred Stock	C - Conversion	I	8.86		-110,323		0
2004-02-06	2002-10-21	4	ELAN CORP PLC I	DOR	Common Stock	C - Conversion	I		8.8600	1,245,187	11,032		1,552,879

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）

SNGX / Soligenix, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5